Framingham-based tools to calculate the global risk of coronary heart disease

AbstractPURPOSE: To examine the features of available Framingham-based risk calculation tools and review their accuracy and feasibility in clinical practice. DATA SOURCES:medline, 1966–April 2003, and the google search engine on the Internet. TOOL AND STUDY SELECTION: We included risk calculation tools that used the Framingham risk equations to generate a global coronary heart disease (CHD) risk. To determine tool accuracy, we reviewed all articles that compared the performance of various Framingham-based risk tools to that of the continuous Framingham risk equations. To determine the feasibility of tool use in clinical practice, we reviewed articles on the availability of the risk factor information required for risk calculation, subjective preference for 1 risk calculator over another, or subjective ease of use. DATA EXTRACTION: Two reviewers independently reviewed the results of the literature search, all websites, and abstracted all articles for relevant information. DATA SYNTHESIS: Multiple CHD risk calculation tools are available, including risk charts and computerized calculators for personal digital assistants, personal computers, and web-based use. Most are easy to use and available without cost. They require information on age, smoking status, blood pressure, total and HDL cholesterol, and the presence or absence of diabetes. Compared to the full Framingham equations, accuracy for identifying patients at increased risk was generally quite high. Data on the feasibility of tool use was limited. CONCLUSIONS: Several easy-to-use tools are available for estimating patients’ CHD risk. Use of such tools could facilitate better decision making about interventions for primary prevention of CHD, but further research about their actual effect on clinical practice and patient outcomes is required. DISCLOSURE: Drs. Sheridan and Pignone have participated in the development of Heart-to-Heart, one of the risk tools evaluated within. They have also received speaking and consulting fees from Bayer, Inc. Bayer, Inc. has licensed the Heart-to-Heart tool.

[1]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[2]  J. McCormack,et al.  Primary prevention of heart disease and stroke: a simplified approach to estimating risk of events and making drug treatment decisions. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[3]  G. Mancia,et al.  Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.

[4]  J B McKinlay,et al.  Accuracy of perceptions of heart attack risk: what influences perceptions and can they be changed? , 1989, American journal of public health.

[5]  W A Bartlett,et al.  Comparative accuracy of cardiovascular risk prediction methods in primary care patients , 2001, Heart.

[6]  V. Fuster,et al.  AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Journal of the American College of Cardiology.

[7]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[8]  W. Bartlett,et al.  Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus , 2001, Diabetes, obesity & metabolism.

[9]  B. Karlsmose,et al.  General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. , 2002, The Journal of family practice.

[10]  P. Greenland,et al.  Risk Factors for Coronary Heart Disease in Men 18 to 39 Years of Age , 2001, Annals of Internal Medicine.

[11]  L. Ramsay,et al.  Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table , 1996, The Lancet.

[12]  H Tunstall-Pedoe,et al.  The Dundee coronary risk-disk for management of change in risk factors. , 1991, BMJ.

[13]  E. Laerum,et al.  Assessment of coronary heart disease risk, I. A postal inquiry among primary care physicians. , 1994, Family Practice.

[14]  Anthony Rodgers,et al.  Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk , 2003, The Lancet.

[15]  Philip Greenland,et al.  Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations , 1999 .

[16]  C. Naylor,et al.  Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self‐assessing coronary risk , 2002, Health expectations : an international journal of public participation in health care and health policy.

[17]  S. Pocock,et al.  Identifying men at high risk of heart attacks: strategy for use in general practice. , 1986, British medical journal.

[18]  D L McGee,et al.  How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts. , 1999, American heart journal.

[19]  S M Grundy,et al.  Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 1999, Circulation.

[20]  F. Hobbs,et al.  Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study , 2002, BMJ : British Medical Journal.

[21]  T. Fahey,et al.  Estimation of cardiovascular risk in hypertensive patients in primary care. , 2000, The British journal of general practice : the journal of the Royal College of General Practitioners.

[22]  K. Yeo,et al.  Predicting CHD risk in patients with diabetes mellitus , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[23]  E. Laerum,et al.  Assessment of coronary heart disease risk, II. A clinical multicentre study of general practitioners' risk assessment. , 1994, Family practice.

[24]  V. Strecher,et al.  Interactive multimedia and risk communication. , 1999, Journal of the National Cancer Institute. Monographs.

[25]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[26]  V. Fuster,et al.  AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Circulation.

[27]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[28]  David C. Atkins,et al.  Screening and treating adults for lipid disorders. , 2001, American journal of preventive medicine.

[29]  D. Bhatnagar,et al.  Indications for cholesterol-lowering medication: comparison of risk-assessment methods , 1999, The Lancet.

[30]  S M Grundy,et al.  Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. , 2001, Circulation.

[31]  D Kromhout,et al.  Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart , 2000, Heart.

[32]  A. Dyer,et al.  Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. , 2001, Archives of internal medicine.

[33]  M. Abrahamowicz,et al.  Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study , 1995, BMJ.

[34]  R. Cooper,et al.  Prediction of coronary heart disease mortality in blacks and whites: pooled data from two national cohorts. , 1999, The American journal of cardiology.

[35]  R. D'Agostino,et al.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.

[36]  A. Menotti,et al.  Prediction of coronary heart disease in Europe. The 2nd report of the WHO-ERICA Project. ERICA Research Group. , 1991, European heart journal.

[37]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[38]  P E Puddu,et al.  Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. , 2000, European heart journal.

[39]  R. Jung,et al.  Controlled trial of effect of documented cardiovascular risk scores on prescribing , 2003, BMJ : British Medical Journal.

[40]  C. Mulrow,et al.  Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[41]  I. U. Haq,et al.  Coronary and cardiovascular risk estimation for primary prevention:validation of a new Sheffield table in the 1995 Scottish health survey population , 2000, BMJ : British Medical Journal.

[42]  V. Strecher,et al.  Changing inaccurate perceptions of health risk: results from a randomized trial , 1995 .

[43]  Daniel Levy,et al.  Lifetime risk of developing coronary heart disease , 1999, The Lancet.

[44]  A. Dyer,et al.  Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. , 2000, JAMA.

[45]  K. Anderson,et al.  Cardiovascular disease risk profiles. , 1991, American heart journal.

[46]  R. Jackson,et al.  Updated New Zealand cardiovascular disease risk-benefit prediction guide , 2000, BMJ : British Medical Journal.

[47]  M. Mayo-Smith,et al.  Differences in Generalists' and Cardiologists' Perceptions of Cardiovascular Risk and the Outcomes of Preventive Therapy in Cardiovascular Disease , 1996, Annals of Internal Medicine.

[48]  François Gueyffier,et al.  A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials , 2001, BMJ : British Medical Journal.

[49]  A. Wierzbicki,et al.  A Comparison of Algorithms for Initiation of Lipid Lowering Therapy in Primary Prevention of Coronary Heart Disease , 2000, Journal of Cardiovascular Risk.

[50]  E. Ashley,et al.  An evidence-based review of the resting electrocardiogram as a screening technique for heart disease. , 2001, Progress in cardiovascular diseases.

[51]  P Degoulet,et al.  Do physicians estimate reliably the cardiovascular risk of hypertensive patients?. , 1995, Medinfo. MEDINFO.

[52]  M. Abrahamowicz,et al.  Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). , 1998, Preventive medicine.

[53]  Zodpey Sp,et al.  A risk scoring system for prediction of coronary heart disease based on multivariate analysis: development and validation. , 1994 .

[54]  R. D'Agostino,et al.  Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. , 2000, Circulation.

[55]  M. Moser.  Detection, evaluation, and treatment of high blood pressure. , 1977, New York state journal of medicine.

[56]  J. Norrie,et al.  Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods , 2000, BMJ : British Medical Journal.

[57]  R B D'Agostino,et al.  Cardiovascular Risk Assessment Based on US Cohort Studies: Findings From a National Heart, Lung, and Blood Institute Workshop , 2001, Circulation.